FDA approves first CAR T-cell therapy for adults with leukemia or lymphoma

by Lori SolomonThe U.S. Food and Drug Administration has approved Bristol Myers Squibb's Breyanzi (lisocabtagene maraleucel [liso-cel]) as the first CD19-directed chimeric antigen receptor (CAR) T

Updated on: March 30,2024

FDA approves first CAR T-cell therapy for adults with leukemia or lymphoma

by Lori SolomonThe U.S. Food and Drug Administration has approved Bristol Myers Squibb's Breyanzi (lisocabtagene maraleucel [liso-cel]) as the first CD19-directed chimeric antigen receptor (CAR) T

Updated on:March 30,2024

Mechanism facilitates brain metastasis from breast cancer and melanoma by inducing neuroinflammation

byTel-Aviv UniversityBrain metastatic burden and survival in mice injected with breast cancer cells. a. Experimental scheme analyzed in (b,c). b. Survival curve analysis of WT and Lcn2-/-m

Updated on: January 07,2024

Mechanism facilitates brain metastasis from breast cancer and melanoma by inducing neuroinflammation

byTel-Aviv UniversityBrain metastatic burden and survival in mice injected with breast cancer cells. a. Experimental scheme analyzed in (b,c). b. Survival curve analysis of WT and Lcn2-/-m

Updated on:January 07,2024

New Co-STAR T cells show promise for treating cancers in laboratory study

byJohns Hopkins University School of MedicineNew cell type, called Co-STAR, fights cancer cells. Credit: Elizabeth CookUsing genetic engineering techniques, investigators at the Johns Hopkins Ki

Updated on: July 11,2024

New Co-STAR T cells show promise for treating cancers in laboratory study

byJohns Hopkins University School of MedicineNew cell type, called Co-STAR, fights cancer cells. Credit: Elizabeth CookUsing genetic engineering techniques, investigators at the Johns Hopkins Ki

Updated on:July 11,2024

Exploring the role of RNA modification in normal hematopoiesis and acute myeloid leukemia pathogenesis

by Cactus CommunicationsThe review sheds light on the role of post-transcriptional RNA modifications in normal hematopoietic development and acute myeloid leukemia, and highlights novel therapeutic ta

Updated on: April 28,2024

Exploring the role of RNA modification in normal hematopoiesis and acute myeloid leukemia pathogenesis

by Cactus CommunicationsThe review sheds light on the role of post-transcriptional RNA modifications in normal hematopoietic development and acute myeloid leukemia, and highlights novel therapeutic ta

Updated on:April 28,2024

Tumor-infiltrating lymphocyte therapy marks a milestone in cancer treatment, researchers say

byH. Lee Moffitt Cancer Center & Research InstituteCancer cell during cell division. Credit: National Institutes of HealthThe recent U.S. Food and Drug Administration approval of lifileucel,

Updated on: August 03,2024

Tumor-infiltrating lymphocyte therapy marks a milestone in cancer treatment, researchers say

byH. Lee Moffitt Cancer Center & Research InstituteCancer cell during cell division. Credit: National Institutes of HealthThe recent U.S. Food and Drug Administration approval of lifileucel,

Updated on:August 03,2024

Anticancer vaccines gain new lease of life with personalisation techniques

by European Society for Medical OncologyCredit: CC0 Public DomainAnticancer vaccines have gained a new lease of life with techniques to personalise them to individual patients. Cutting edge devel

Updated on: March 01,2024

Anticancer vaccines gain new lease of life with personalisation techniques

by European Society for Medical OncologyCredit: CC0 Public DomainAnticancer vaccines have gained a new lease of life with techniques to personalise them to individual patients. Cutting edge devel

Updated on:March 01,2024

Researchers report method to determine the absolute dose for new radiotherapy cancer treatment technique

by National Physical LaboratoryExperimental setup mounted on the patient couch and radiograph of the NPL PSPC. (a) (1) Gantry, (2) NPL PSPC, (3) measurement instrumentation for the NPL PSPC, (4)

Updated on: February 01,2024

Researchers report method to determine the absolute dose for new radiotherapy cancer treatment technique

by National Physical LaboratoryExperimental setup mounted on the patient couch and radiograph of the NPL PSPC. (a) (1) Gantry, (2) NPL PSPC, (3) measurement instrumentation for the NPL PSPC, (4)

Updated on:February 01,2024

New circulating tumor DNA test measures multiple markers to detect cancer early

byeLifeCredit: CC0 Public DomainResearchers have developed a method that simultaneously measures different cancer-specific hallmarks of DNA circulating in the blood, aiding early detection and l

Updated on: January 12,2024

New circulating tumor DNA test measures multiple markers to detect cancer early

byeLifeCredit: CC0 Public DomainResearchers have developed a method that simultaneously measures different cancer-specific hallmarks of DNA circulating in the blood, aiding early detection and l

Updated on:January 12,2024

New study explores challenges and opportunities for cancer research

by Richard Harth,Arizona State UniversityA recent review by Carlo Maley, a researcher at Arizona State University, and Lucie Laplane from the University of Paris Pantheon-Sorbonne critiques the

Updated on: September 25,2024

New study explores challenges and opportunities for cancer research

by Richard Harth,Arizona State UniversityA recent review by Carlo Maley, a researcher at Arizona State University, and Lucie Laplane from the University of Paris Pantheon-Sorbonne critiques the

Updated on:September 25,2024

Renal impairment linked to worse prognosis in IgD multiple myeloma

by Elana GotkineFor patients with immunoglobulin D multiple myeloma (IgD MM), those with renal impairment (RI) have poorer prognosis and shorter median survival than those with no renal impairment (no

Updated on: January 04,2024

Renal impairment linked to worse prognosis in IgD multiple myeloma

by Elana GotkineFor patients with immunoglobulin D multiple myeloma (IgD MM), those with renal impairment (RI) have poorer prognosis and shorter median survival than those with no renal impairment (no

Updated on:January 04,2024

Researchers discover new molecular driver of retinoblastoma

byUT Southwestern Medical CenterInactive remnant of retinoblastoma tumor following successful intra-arterial chemotherapy. Credit: UT Southwestern Medical CenterDespite decades of medical advanc

Updated on: January 30,2024

Researchers discover new molecular driver of retinoblastoma

byUT Southwestern Medical CenterInactive remnant of retinoblastoma tumor following successful intra-arterial chemotherapy. Credit: UT Southwestern Medical CenterDespite decades of medical advanc

Updated on:January 30,2024

Team develops tools and techniques to explore cancer signals at the subcellular level

by Jerry Grillo,Georgia Institute of TechnologyGraphical abstract. Credit:iScience(2022). DOI: 10.1016/j.isci.2022.104980This year, about 240,000 people in the U.S. will discover the

Updated on: January 08,2024

Team develops tools and techniques to explore cancer signals at the subcellular level

by Jerry Grillo,Georgia Institute of TechnologyGraphical abstract. Credit:iScience(2022). DOI: 10.1016/j.isci.2022.104980This year, about 240,000 people in the U.S. will discover the

Updated on:January 08,2024